LXRX·528872302·US·equity·Healthcare - Biotechnology-Activist
LXRX (LEXICON PHARMACEUTICALS INC) is held by 68 institutional investors as of Q1 2026. Largest holders: FMR LLC ($70.3M), Point72 Asset Management, L.P. ($12.2M), MILLENNIUM MANAGEMENT LLC ($7.7M). Net institutional sentiment: Mixed.
See how LXRX's score breaks down across 4 SEC sources
Showing 1-20 of 75
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer